Phase 3 Metastatic Colorectal Cancer (MCRC)
The purpose of the study is to assess the progression free survival and overall survival of patients treated with Aptocine plus chemotherapy versus chemotherapy alone in the treatment of colorectal cancer with recurrent liver metastases, and to demonstrate the safety of Aptocine.
For more information about this trial, please visit the trial registration page at ClinicalTrials.gov: